Skip to main navigation Skip to search Skip to main content

A Randomized, Open-label Study of HLX10 plus Chemotherapy (Carboplatin-Etoposide) in comparison with Atezolizumab plus Chemotherapy in Previously Untreated US Patients with Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Project: Research

Project Details

StatusActive
Effective start/end date11/30/23 → 01/1/27

Funding

  • Shanghai Henlius Biotech Incorporated: $295,592.00